In the case of T1DM, alterations in miRNA levels may contribute to the disease pathogenesis by affecting multiple pathways, such as insulin secretion, the programmed cell death, the immune system, and the mitogen-activated protein kinase (MAPK) signaling pathway (61). The gene discussed is INS; the disease is type 1 diabetes mellitus.